Terms: = Head and neck cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
30 results:
1. ΔNp63 overexpression promotes oral cancer cell migration through hyperactivated Activin A signaling.
Mundhe D; Mishra R; Basu S; Dalal S; Kumar S; Teni T
Exp Cell Res; 2023 Oct; 431(1):113739. PubMed ID: 37567436
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
3. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.
Yang K; Xie Y; Xue L; Li F; Luo C; Liang W; Zhang H; Li Y; Ren Y; Zhao M; Wang W; Liu J; Shen X; Zhou W; Fei J; Chen W; Gu W; Wang L; Li F; Hu J
J Transl Med; 2023 Jan; 21(1):26. PubMed ID: 36641471
[TBL] [Abstract] [Full Text] [Related]
4. Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma.
Chang JW; Seo ST; Im MA; Won HR; Liu L; Oh C; Jin YL; Piao Y; Kim HJ; Kim JT; Jung SN; Koo BS
Transl Res; 2022 Sep; 247():58-78. PubMed ID: 35462077
[TBL] [Abstract] [Full Text] [Related]
5. CircFOXM1 acts as a ceRNA to upregulate smad2 and promote the progression of nasopharyngeal carcinoma.
Pei S; Ma C; Chen J; Hu X; Du M; Xu T; Zhan M; Xue K; Zhang Y; Yin L; He X
Mol Genet Genomic Med; 2022 May; 10(5):e1914. PubMed ID: 35266323
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/smad2 axis in retinoblastoma.
Yin DF; Zhou XJ; Li N; Liu HJ; Yuan H
Bioengineered; 2021 Dec; 12(1):1189-1201. PubMed ID: 34969359
[TBL] [Abstract] [Full Text] [Related]
7. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma.
Liu F; Wu Q; Han W; Laster K; Hu Y; Ma F; Chen H; Tian X; Qiao Y; Liu H; Kim DJ; Dong Z; Liu K
Clin Transl Med; 2021 Oct; 11(10):e548. PubMed ID: 34709754
[TBL] [Abstract] [Full Text] [Related]
8. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
Wang F; Zhang C; Cheng H; Liu C; Lu Z; Zheng S; Wang S; Sun N; He J
Cell Death Dis; 2021 Oct; 12(10):901. PubMed ID: 34601488
[TBL] [Abstract] [Full Text] [Related]
9. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract] [Full Text] [Related]
10. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract] [Full Text] [Related]
11. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract] [Full Text] [Related]
12. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
[TBL] [Abstract] [Full Text] [Related]
13. Oncogenic activity of poly (ADP-ribose) glycohydrolase.
Marques M; Jangal M; Wang LC; Kazanets A; da Silva SD; Zhao T; Lovato A; Yu H; Jie S; Del Rincon S; Mackey J; Damaraju S; Alaoui-Jamali M; Witcher M
Oncogene; 2019 Mar; 38(12):2177-2191. PubMed ID: 30459355
[TBL] [Abstract] [Full Text] [Related]
14. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
[TBL] [Abstract] [Full Text] [Related]
15. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent head and neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract] [Full Text] [Related]
16. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract] [Full Text] [Related]
17. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
[TBL] [Abstract] [Full Text] [Related]
18. Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.
Li P; Chen X; Qin G; Yue D; Zhang Z; Ping Y; Wang D; Zhao X; Song M; Zhao Q; Li J; Liu S; Wang D; Zhang C; Lian J; Cao L; Li F; Huang L; Wang L; Yang L; Huang J; Li H; Zhang B; Zhang Y
Cancer Immunol Res; 2018 Oct; 6(10):1246-1259. PubMed ID: 30082413
[No Abstract] [Full Text] [Related]
19. TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis.
Deng C; Lin YX; Qi XK; He GP; Zhang Y; Zhang HJ; Xu M; Feng QS; Bei JX; Zeng YX; Feng L
Cancer Res; 2018 Jul; 78(13):3469-3483. PubMed ID: 29735548
[TBL] [Abstract] [Full Text] [Related]
20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract] [Full Text] [Related]
[Next]
